EP1940417A4 - METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE - Google Patents

METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE

Info

Publication number
EP1940417A4
EP1940417A4 EP06826544A EP06826544A EP1940417A4 EP 1940417 A4 EP1940417 A4 EP 1940417A4 EP 06826544 A EP06826544 A EP 06826544A EP 06826544 A EP06826544 A EP 06826544A EP 1940417 A4 EP1940417 A4 EP 1940417A4
Authority
EP
European Patent Office
Prior art keywords
treating
associated diarrhea
difficult clostridium
clostridium associated
difficult
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06826544A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1940417A2 (en
Inventor
Pamela Sears
Youe-Kong Shue
Starr Louise Miller-Shangle
Robert Brian Walsh
Farah Babakhani
Yu-Hung Chiu
Alex Romero
Sherwood Gorbach
Thomas John Louie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Optimer Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimer Pharmaceuticals LLC filed Critical Optimer Pharmaceuticals LLC
Publication of EP1940417A2 publication Critical patent/EP1940417A2/en
Publication of EP1940417A4 publication Critical patent/EP1940417A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06826544A 2005-10-21 2006-10-23 METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE Withdrawn EP1940417A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72913505P 2005-10-21 2005-10-21
US74964105P 2005-12-12 2005-12-12
PCT/US2006/041436 WO2007048059A2 (en) 2005-10-21 2006-10-23 Method of treating clostridium difficile-associated diarrhea

Publications (2)

Publication Number Publication Date
EP1940417A2 EP1940417A2 (en) 2008-07-09
EP1940417A4 true EP1940417A4 (en) 2010-07-07

Family

ID=37963388

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06826544A Withdrawn EP1940417A4 (en) 2005-10-21 2006-10-23 METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE

Country Status (7)

Country Link
EP (1) EP1940417A4 (enExample)
JP (1) JP2009512691A (enExample)
KR (1) KR101399621B1 (enExample)
CN (2) CN101340919B (enExample)
AU (1) AU2006304868B2 (enExample)
CA (1) CA2626698C (enExample)
WO (1) WO2007048059A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
CN104846044B (zh) * 2014-02-17 2019-02-01 上海医药工业研究院 一种提高非达霉素产量的发酵培养基
CN105237599B (zh) * 2015-10-09 2018-10-02 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法
CN107970253B (zh) * 2017-10-25 2020-05-26 中山大学 台勾霉素衍生物在制备治疗寨卡病毒感染引起的相关疾病和/或症状的药物中的应用
CN107714713B (zh) * 2017-10-25 2020-05-26 中山大学 台勾霉素衍生物在制备治疗登革病毒感染引起的相关疾病和/或症状的药物中的应用
EP4242295B1 (en) * 2018-06-07 2024-08-28 Artugen Therapeutics Ltd. B. amyloliquefaciens strain and therapeutic use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
WO2005112990A2 (en) * 2004-05-14 2005-12-01 Optimer Pharmaceuticals, Inc. Treatment of diseases associated with the use of antibiotics
WO2006085838A1 (en) * 2005-01-31 2006-08-17 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
WO2004014295A2 (en) * 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
WO2005112990A2 (en) * 2004-05-14 2005-12-01 Optimer Pharmaceuticals, Inc. Treatment of diseases associated with the use of antibiotics
WO2006085838A1 (en) * 2005-01-31 2006-08-17 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof

Also Published As

Publication number Publication date
CA2626698A1 (en) 2007-04-26
CA2626698C (en) 2015-12-01
WO2007048059A3 (en) 2007-05-31
CN101340919B (zh) 2011-12-07
CN101340919A (zh) 2009-01-07
EP1940417A2 (en) 2008-07-09
CN102503994A (zh) 2012-06-20
KR101399621B1 (ko) 2014-06-18
HK1126410A1 (en) 2009-09-04
JP2009512691A (ja) 2009-03-26
KR20080064177A (ko) 2008-07-08
WO2007048059A2 (en) 2007-04-26
AU2006304868A1 (en) 2007-04-26
AU2006304868B2 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
EP1917392A4 (en) OPERATING PROCESS FOR WASHING MACHINE
BRPI0716508A2 (pt) Processo de recuperação de hidrocarbonetos
EP1861533A4 (en) METHOD OF WASHING A WASHING MACHINE
EP2121811A4 (en) PROCESS FOR PREPARING A DISPERSION
EP2056855A4 (en) METHOD FOR THE TREATMENT OF PHOTODERMATOSES
ATE428818T1 (de) Verfahren zum bleichen von substraten
BRPI0719786A2 (pt) Método para máquina de lavar roupas com enxágue
DE502008000519D1 (de) Bedienpult für eine Werkzeugmaschine
DE602005003296D1 (de) Revolver für Werkzeugmaschine
EP1940417A4 (en) METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE
DE602005011110D1 (de) Ausgleichmechanismus für Werkzeugmaschine
DE602007001537D1 (de) Modulares System zum Schnee-reisen für Schuhwerk
FR2892409B1 (fr) Procede de traitement d'un substrat
FR2942559B1 (fr) Procede de protection du code source d'un programme d'ordinateur.
FR2919402B1 (fr) Procede de test d'une application logicielle.
FI20050160A0 (fi) Menetelmä kuparipitoisten materiaalien käsittelemiseksi
FI20055665L (fi) Prosessi haarautuneen hiilivetykomponentin valmistamiseksi
DE602004023707D1 (de) Waschverfahren für eine Waschmaschine
FI20055666L (fi) Prosessi hiilivetykomponentin valmistamiseksi
DE112006002256A5 (de) Verfahren zum Betrieb einer elektrischen Maschine
IL186292A0 (en) Method of treating multiple myeloma using 17-aag of 17-ag of a prodrug of either
FR2907542B1 (fr) Procede de selection d'un trajet routier.
EP1934388A4 (en) Method of drug design
DE502006001388D1 (de) Verfahren zum betreiben einer Erweiterungskarte
DK1986840T3 (da) Maskine til dækning af forskellige typer artikler

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080425

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20100609

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/04 20060101ALI20100602BHEP

Ipc: A61K 45/06 20060101ALI20100602BHEP

Ipc: A61K 31/70 20060101AFI20080428BHEP

17Q First examination report despatched

Effective date: 20110216

17Q First examination report despatched

Effective date: 20110302

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: OPTIMER PHARMACEUTICALS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MERCK SHARP & DOHME CORP.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160202